David M. Knott’s Cidara Therapeutics CDTX Stock Holding History

David M. Knott’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$930K	Hold	20,765	–	–	0.34%	58
2021 Q2	$839K	Hold	20,765	–	–	0.3%	63
2021 Q1	$1.1M	Hold	20,765	–	–	0.47%	48
2020 Q4	$831K	Buy	20,765 +412	+2%	+$20.5K	0.38%	48
2020 Q3	$1.16M	Hold	20,353	–	–	0.68%	34
2020 Q2	$1.5M	Buy	20,353 +250	+1%	+$16.2K	0.82%	30
2020 Q1	$997K	Buy	20,103 +9,192	+84%	+$551K	0.63%	30
2019 Q4	$838K	Buy	10,911 +1,128	+12%	+$51.6K	0.34%	46
2019 Q3	$390K	Buy	9,783 +3,357	+52%	+$113K	0.16%	64
2019 Q2	$216K	Buy	+6,426	New	+$267K	0.09%	73

Other funds holding CDTX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

David M. Knott's CDTX Position: Q3 2021 in Review

David M. Knott held its Cidara Therapeutics (CDTX) position steady in Q3 2021 at 20,765 shares worth $930K. The position accounts for 0.34% of the portfolio, ranked #58.

David M. Knott first reported a position in CDTX in Q2 2019 and has held it in 10 quarters since. The position peaked at $1.5M in Q2 2020. 50 funds tracked by Wall St. Rank hold CDTX as of Q3 2021.

David M. Knott held 20,765 shares of Cidara Therapeutics worth $930K as of Q3 2021.
David M. Knott left its Cidara Therapeutics share count unchanged in Q3 2021.
Cidara Therapeutics made up 0.34% of David M. Knott's portfolio in Q3 2021, its #58 holding.
David M. Knott first reported a position in Cidara Therapeutics in Q2 2019 and has held it in 10 quarters since.
David M. Knott's Cidara Therapeutics position peaked at $1.5M in Q2 2020.
50 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.